Patents-Review.com
ClassID:

21210 ⎘

A61K2039/60 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen

Sub-classes:
Recent Application in this class:
#1
20260137774
2026-05-21

Hepatitis B Virus Receptor OATP and Use Thereof

 #2
20260115300
2026-04-30

GLYCOTARGETING THERAPEUTICS

 #3
20260115275
2026-04-30

RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF

 #4
20260041764
2026-02-12

EXTRACELLULAR VESICLES FOR VACCINE DELIVERY

 #5
20260041757
2026-02-12

THERMOSTABLE MUCOSAL VACCINE COMPOSITIONS AND METHODS

 #6
20260041753
2026-02-12

RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF

 #7
20260041752
2026-02-12

PNEUMOCOCCAL CONJUGATE VACCINES WITH SAPONIN-BASED ADJUVANTS

 #8
20260007723
2026-01-08

GLYCOTARGETING THERAPEUTICS

 #9
20250339516
2025-11-06

METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES

 #10
20250295743
2025-09-25

GLYCOTARGETING THERAPEUTICS

 #11
20250242010
2025-07-31

COMPOSITIONS AND METHODS FOR MAKING AND USING THERMOSTABLE IMMUNOGENIC FORMULATIONS WITH INCREASED COMPATIBILITY OF USE AS VACCINES AGAINST ONE OR MORE PATHOGENS

 #12
20250215439
2025-07-03

IMMUNOSTIMULATORY COMPOSITIONS

 #13
20250206784
2025-06-26

MODIFIED SPIKE PROTEINS AND USES THEREOF

 #14
20250152700
2025-05-15

ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE

 #15
20250121043
2025-04-17

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

 #16
20250114448
2025-04-10

SAPONIN-BASED ADJUVANTS AND VACCINES

 #17
20240416008
2024-12-19

MICROPOROUS ANNEALED PARTICLE GEL SYSTEM

 #18
20240342275
2024-10-17

SYSTEM AND METHOD FOR ANTIBODY ACTIVATORS IN AN AQUEOUS IODINE SOLUTION

 #19
20240299536
2024-09-12

NANOPARTICLE COMPOSITIONS FOR SUSTAINED THERAPY

 #20
20240192236
2024-06-13

Compounds and Methods for Use in Detecting Gabapentin

 #21
20240173390
2024-05-30

PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE

 #22
20240139336
2024-05-02

COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES

 #23
20240050548
2024-02-15

MHC CLASS I ASSOCIATED PEPTIDES FOR PREVENTION AND TREATMENT OF MULTIPLE FLAVI VIRUS

 #24
20240042007
2024-02-08

Fluorocarbon-Linked Peptide Formulation

 #25
20230346908
2023-11-02

MHC class i associated peptides for prevention and treatment of multiple flavi virus

 #26
20230263885
2023-08-24

Extracellular vesicles for vaccine delivery

 #27
20230241204
2023-08-03

POLYPEPTIDE VACCINE COUPLED WITH TLR7 AGONIST FOR NOVEL CORONAVIRUS AND USE THEREOF

 #28
20230233461
2023-07-27

ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION

 #29
20230174990
2023-06-08

Immunostimulatory compositions

 #30
20230139671
2023-05-04

OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS

 #31
20230115331
2023-04-13

GLYCOTARGETING THERAPEUTICS

 #32
20230111132
2023-04-13

STABILIZATION OF MHC COMPLEXES

 #33
20230108299
2023-04-06

GLYCOTARGETING THERAPEUTICS

 #34
20230090379
2023-03-23

Vaccines against hepatitis B virus

 #35
20230062122
2023-03-02

MODIFIED ADENOVIRUSES FOR INFECTIOUS DISEASE VACCINE DEVELOPMENT

 #36
20230045688
2023-02-09

CUSTOMMUNE: A WEB TOOL FOR DESIGNING PERSONALIZED AND POPULATION-TARGETED PEPTIDE VACCINES

 #37
20230030932
2023-02-02

CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER

 #38
20220378888
2022-12-01

SCALABLE AND FACILE CELL-MEMBRANE-COATING TECHNOLOGY FOR BOTH POSITIVELY AND NEGATIVELY CHARGED PARTICLES

 #39
20220370686
2022-11-24

Microporous annealed particle gel system

 #40
20220326263
2022-10-13

Compounds and methods for use in detecting gabapentin

 #41
20220305101
2022-09-29

Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer

 #42
20220305099
2022-09-29

METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS

 #43
20220265810
2022-08-25

Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

 #44
20220168415
2022-06-02

EXTRACELLULAR VESICLES FOR VACCINE DELIVERY

 #45
20220152170
2022-05-19

Peptide vaccine formulations and use thereof for inducing an immune response

 #46
20220151943
2022-05-19

Vaccine delivery systems using yeast cell wall particles

 #47
20220073446
2022-03-10

Antigen Delivery Vectors and Constructs

 #48
20220072023
2022-03-10

COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE

 #49
20220016256
2022-01-20

METHODS, DEVICE AND REAGENTS TO TREAT ALLERGY AND AUTOIMMUNE DISEASE

 #50
20220003793
2022-01-06

Compounds and methods for use in detecting gabapentin

 #51
20210361760
2021-11-25

MHC class I associated peptides for prevention and treatment of multiple flavi virus

 #52
20210348150
2021-11-11

CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA

 #53
20210346478
2021-11-11

Nano-satellite complexes

 #54
20210308251
2021-10-07

Agent for the prevention of viral infections

 #55
20210283237
2021-09-16

VACCINE COMPOSITIONS

 #56
20210275658
2021-09-09

Edible vaccination against microbial pathogens

 #57
20210236623
2021-08-05

T-CELL INDUCING VACCINE COMPOSITION COMBINATION AND USES THEREOF

 #58
20210236608
2021-08-05

Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same

 #59
20210205470
2021-07-08

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS

 #60
20210189012
2021-06-24

Dendritic gold nanoparticles and methods of synthesis

 #61
20210187087
2021-06-24

TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS

 #62
20210170020
2021-06-10

Immunostimulatory compositions

 #63
20210145981
2021-05-20

METHOD OF ATTACKING TARGET CELLS

 #64
20210145949
2021-05-20

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

 #65
20210138089
2021-05-13

Nanoallergens and uses thereof

 #66
20210100883
2021-04-08

Modified adenoviruses for cancer vaccines development

 #67
20210085768
2021-03-25

Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer

 #68
20210038710
2021-02-11

Fluorocarbon-linked peptide formulation

 #69
20200400696
2020-12-24

Compounds and methods for use in detecting gabapentin

 #70
20200385733
2020-12-10

Immunostimulatory oligonucleotides

 #71
20200385376
2020-12-10

Molecules that stimulate the immune system for treatment of drug addiction, methods of synthesis, antidrug vaccine and uses

 #72
20200384100
2020-12-10

Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

 #73
20200368366
2020-11-26

Method of attacking target cells

 #74
20200368172
2020-11-26

Vaccine delivery systems using yeast cell wall particles

 #75
20200330580
2020-10-22

Transcutaneous dosage formulation

 #76
20200308258
2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

 #77
20200306413
2020-10-01

Microporous annealed particle gels and methods of use

 #78
20200129640
2020-04-30

Complexes for delivery of antigenic peptides

 #79
20200129629
2020-04-30

Glycotargeting therapeutics

 #80
20200129601
2020-04-30

Glycotargeting therapeutics

 #81
20200121762
2020-04-23

Glycotargeting therapeutics

 #82
20200095546
2020-03-26

Nanoscale artificial antigen presenting cells

 #83
20200069596
2020-03-05

Vaccine delivery systems using yeast cell wall particles

 #84
20200054559
2020-02-20

Vaccine nanotechnology

 #85
20200023046
2020-01-23

ORAL COMPOSITION AND METHODS FOR IMMUNOTHERAPY

 #86
20200016263
2020-01-16

Vaccines against Hepatitis B virus

 #87
20200009265
2020-01-09

Methods and compositions for treating multiple sclerosis and related disorders

 #88
20190345232
2019-11-14

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

 #89
20190321486
2019-10-24

Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles

 #90
20190240162
2019-08-08

Vaccine delivery systems using yeast cell wall particles

 #91
20190231892
2019-08-01

METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY

 #92
20190216911
2019-07-18

Recombinant protein delivered as nanoparticles

 #93
20190216748
2019-07-18

Tobacco products

 #94
20190175728
2019-06-13

NUCLEIC ACID-ANTIGEN PEPTIDE CONJUGATE

 #95
20190167774
2019-06-06

TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS

 #96
20190167600
2019-06-06

Biomolecule preservation

 #97
20190134189
2019-05-09

Treatment of peanut allergy

 #98
20190134170
2019-05-09

Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same

 #99
20190117688
2019-04-25

Compositions comprising secreted extracellular vesicles of cells expressing NFATC4 useful for the treatment of cancer

 #100
20190060484
2019-02-28

Nanoparticle compositions for sustained therapy

 #101
20190060435
2019-02-28

Peptide vaccine formulations and use thereof for inducing an immune response

 #102
20190046632
2019-02-14

Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

 #103
20180360950
2018-12-20

Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof

 #104
20180360738
2018-12-20

Anti-infection and anti-tumor mucosal immune preparation

 #105
20180311335
2018-11-01

Cell surface anchoring antigen conjugates to treat cancer

 #106
20180303951
2018-10-25

Glycotargeting therapeutics

 #107
20180289820
2018-10-11

Immunogenic compositions and reagents for preparing

 #108
20180280534
2018-10-04

Methods and compositions for liposomal formulation of antigens and uses thereof

 #109
20180280491
2018-10-04

Immunogenic compositions against

#110
20180272008
2018-09-27

Nanoallergens and uses thereof

 #111
20180237762
2018-08-23

CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA

 #112
20180214529
2018-08-02

Edible vaccination against microbial pathogens

 #113
20180207255
2018-07-26

Immunogenic compositions containing bacterial outer membrane vesicles

 #114
20180170978
2018-06-21

Modular antigen transportation molecules and uses therof

 #115
20180161283
2018-06-14

Methods and products for treating and/or delaying onset of dysplastic lesions

 #116
20180154020
2018-06-07

Method of attacking target cells

 #117
20180092983
2018-04-05

METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY

 #118
20180080044
2018-03-22

Swine influenza vaccine

 #119
20180080043
2018-03-22

EHV insertion site ORF70

 #120
20180071381
2018-03-15

Transcutaneous vaccine formulations and methods

 #121
20170348401
2017-12-07

Gas-filled microvesicles for use as vaccine

 #122
20170333540
2017-11-23

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

 #123
20170312348
2017-11-02

Methods and compositions for treating multiple sclerosis and related disorders

 #124
20170202902
2017-07-20

Conjugates for immunotherapy

 #125
20170189503
2017-07-06

PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same

 #126
20170173164
2017-06-22

Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

 #127
20170157266
2017-06-08

Methods and compositions for liposomal formulation of antigens and uses thereof

 #128
20170138970
2017-05-18

Compounds and methods for use in detecting gabapentin

 #129
20170119875
2017-05-04

Amino sphingoglycolipid analogues

 #130
20170106068
2017-04-20

ORAL COMPOSITION AND METHODS FOR IMMUNOTHERAPY

 #131
20170095544
2017-04-06

Nanoparticle compositions for sustained therapy

 #132
20170081659
2017-03-23

Compositions and methods for immunodominant antigens

 #133
20170080069
2017-03-23

Modified adenoviruses for cancer vaccines development

 #134
20170065532
2017-03-09

Vaccine delivery systems using yeast cell wall particles

 #135
20170049898
2017-02-23

Influenza antigen delivery vectors and constructs

 #136
20170023586
2017-01-26

Compositions and methods for immunodominant antigens of

#137
20160271237
2016-09-22

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

 #138
20160250352
2016-09-01

SHIELDED BIOLOGIC THERAPEUTIC

 #139
20160243248
2016-08-25

Glycotargeting therapeutics

 #140
20160200758
2016-07-14

1,2,3-triazole-tethered carbohydrate-di and tri lipidated cysteine conjugates useful as vaccine adjuvants and process for preparation thereof

 #141
20160199498
2016-07-14

Peptides for enhancing transdermal delivery

 #142
20160106830
2016-04-21

Vaccines against hepatitis B virus

 #143
20160051698
2016-02-25

Nanoscale artificial antigen presenting cells

 #144
20160051664
2016-02-25

Recombinant polynucleotide and a transgenic carrying the same

 #145
20160051661
2016-02-25

Fluorocarbon-linked peptide formulation

 #146
20160022800
2016-01-28

Transcutaneous haemophilus influenzae vaccine formulations and methods

 #147
20160015821
2016-01-21

Glycotargeting therapeutics

 #148
20150374815
2015-12-31

METHODS AND COMPOSITIONS FOR TREATMENT WITH SYNTHETIC NANOCARRIERS AND IMMUNE CHECKPOINT INHIBITORS

 #149
20150352218
2015-12-10

Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

 #150
20150274790
2015-10-01

Modular antigen transportation molecules and uses therof

 #151
20150209446
2015-07-30

Methods and compositions for treating multiple sclerosis and related disorders

 #152
20150168401
2015-06-18

Compositions and methods for immunodominant antigens of

#153
20150112042
2015-04-23

Antigen delivery vectors and constructs

 #154
20150104481
2015-04-16

Water extract of for immunostimulatory effect and preparation method thereof

 #155
20150024456
2015-01-22

Compounds and methods for use in detecting gabapentin

 #156
20150023987
2015-01-22

Immunogenic compositions and reagents for preparing

 #157
20140341938
2014-11-20

Nanoparticle-peptide compositions

 #158
20140314865
2014-10-23

Vaccine nanotechnology

 #159
20140308341
2014-10-16

Methods and compositions for liposomal formulation of antigens and uses thereof

 #160
20140234356
2014-08-21

Influenza antigen delivery vectors and constructs

 #161
20140106455
2014-04-17

Process for preparing vaccine composition

 #162
20130330382
2013-12-12

Fluorocarbon-linked peptide formulation

 #163
20130295147
2013-11-07

Methods of using gas-filled microvesicles covalently bound to an antigen

 #164
20130287857
2013-10-31

Vaccine nanotechnology

 #165
20130273047
2013-10-17

Clotting factor-Fc chimeric proteins to treat hemophilia

 #166
20130236533
2013-09-12

Vaccine nanotechnology

 #167
20130202655
2013-08-08

Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration

 #168
20130165382
2013-06-27

Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives

 #169
20130095173
2013-04-18

Multivalent glycopeptide constructs and uses thereof

 #170
20130084306
2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

 #171
20130072398
2013-03-21

Compositions and methods for immunodominant antigens of

#172
20130064854
2013-03-14

METHODS OF TREATING ALLERGIES WITH SUBSTANTIALLY PHENOL-FREE CARRIERS

 #173
20130045231
2013-02-21

Immunogenic composition

 #174
20130017219
2013-01-17

PURIFICATION OF BACTERIAL VESICLES

 #175
20130011429
2013-01-10

IMMUNOGENIC COMPOSITION

 #176
20130004530
2013-01-03

VACCINE COMPOSITION

 #177
20120315293
2012-12-13

Antigen delivery vectors and constructs

 #178
20120308660
2012-12-06

NANOCOATINGS FOR BIOLOGICAL MATERIALS

 #179
20120244222
2012-09-27

OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS

 #180
20120142555
2012-06-07

Compositions and methods for immunodominant antigens of

#181
20120082725
2012-04-05

Composition comprising immunogenic microparticles

 #182
20120077965
2012-03-29

Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines

 #183
20120034259
2012-02-09

Antigen delivery vectors and constructs

 #184
20120009254
2012-01-12

Respiratory syncytial virus antigenic compositions and methods

 #185
20110311565
2011-12-22

Phage constructs, sequences and antigenic compositions for immunocontraception of animals

 #186
20110275146
2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

 #187
20110262529
2011-10-27

Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof

 #188
20110250217
2011-10-13

Methods and compositions for eliciting an amyloid-selective immune response

 #189
20110245099
2011-10-06

Compositions and methods for immunodominant antigens of

#190
20110236425
2011-09-29

Anthrax vaccine formulation and uses thereof

 #191
20110182896
2011-07-28

Clotting factor-fc chimeric proteins to treat hemophilia

 #192
20110142911
2011-06-16

HIV epitopes and pharmaceutical composition containing same

 #193
20110081382
2011-04-07

Treatment and prevention of tuberculosis

 #194
20110059121
2011-03-10

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

 #195
20110008450
2011-01-13

Slow release compositions

 #196
20100330161
2010-12-30

Oral delivery of tetanus toxoid

 #197
20100291680
2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

 #198
20100285051
2010-11-11

VACCINE

 #199
20100272776
2010-10-28

Device including bone cage and method for treatment of disease in a subject

 #200
20100272772
2010-10-28

Apparatus, system, and method for creating immunologically enhanced spaces in-vivo

 #201
20100272771
2010-10-28

Device including bone cage and method for treatment of disease in a subject

 #202
20100233251
2010-09-16

Vaccine nanotechnology

 #203
20100227404
2010-09-09

WATER EXTRACT OF ANTRODIA CAMPHORATA FOR IMMUNOSTIMULATORY EFFECT AND PREPARATION METHOD THEREOF

 #204
20100226973
2010-09-09

Methods and compositions for liposomal formulation of antigens and uses thereof

 #205
20100203082
2010-08-12

Virus-modified bacteria ghosts

 #206
20100183708
2010-07-22

Antigen delivery vectors and constructs

 #207
20100183650
2010-07-22

Antigen delivery vectors and constructs

 #208
20100158951
2010-06-24

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

 #209
20100136043
2010-06-03

Composition comprising immunogenic microparticles

 #210
20100119535
2010-05-13

Compositions and methods for immunodominant antigens

 #211
20100092524
2010-04-15

Modification of exosomal components for use as a vaccine

 #212
20100074914
2010-03-25

DNA vaccine comprising CTGF-encoding DNA construct and applications thereof

 #213
20100021486
2010-01-28

TSLP VACCINE FOR THE TREATMENT OF TH2 MEDIATED INFLAMMATORY CONDITIONS

 #214
20090297552
2009-12-03

FLAGELLIN POLYPEPTIDE VACCINES

 #215
20090285847
2009-11-19

Compositions and methods for immunodominant antigens of

#216
20090285814
2009-11-19

CD 40 Binding Molecules and CTL Pepetides for Treating Tumors

 #217
20090214663
2009-08-27

Virus coated nanoparticles and uses thereof

 #218
20090191233
2009-07-30

Influenza antigen delivery vectors and constructs

 #219
20090191149
2009-07-30

IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS

 #220
20090155292
2009-06-18

Compositions and methods for the prevention and treatment of autoimmune conditions

 #221
20090081156
2009-03-26

Bioactive molecular matrix and methods of use in the treatment of disease

 #222
20080292704
2008-11-27

Methods and compositions involving polymeric immunoglobulin fusion proteins

 #223
20080274134
2008-11-06

Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex

 #224
20080260773
2008-10-23

Saccharide Conjugate Vaccines

 #225
20080241195
2008-10-02

Optimal Polyvalent Vaccine for Cancer

 #226
20080199887
2008-08-21

Compounds and methods for use in detecting gabapentin

 #227
20080193474
2008-08-14

Immunostimulatory Compositions

 #228
20080171059
2008-07-17

METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS

 #229
20080152648
2008-06-26

Compositions and methods for enhancing an adjuvant

 #230
20080050399
2008-02-28

IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS

 #231
20080039816
2008-02-14

Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging

 #232
20070275007
2007-11-29

Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer

 #233
20070202123
2007-08-30

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

 #234
20070179083
2007-08-02

Covalent attachment of ligands to nucleophilic proteins guided by non-covalent

 #235
20070071776
2007-03-29

Recombinant Vaccine Against Fish Infectious Diseases

 #236
20070037141
2007-02-15

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

 #237
20060252033
2006-11-09

Carrier of a diamond fine particle for immobilizing virus

 #238
20060134141
2006-06-22

Glycoconjugate vaccines containing peptidoglycan

 #239
20060045885
2006-03-02

Method of eliciting an immune response against HIV

 #240
20060035267
2006-02-16

Optimal polyvalent vaccine for cancer

 #241
20060013820
2006-01-19

Antigen delivery vectors and constructs

 #242
20050148529
2005-07-07

Nucleic acid immunization

 #243
20050147618
2005-07-07

Clotting factor-Fc chimeric proteins to treat hemophilia

 #244
20050089526
2005-04-28

Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

 #245
20050037017
2005-02-17

Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins

 #246
20050025777
2005-02-03

Particle-mediated delivery of antigens